Effect of Amniotic Fluid Stem Cells and Amniotic Fluid Cells on the Wound Healing Process in a White Rat Model

Background Amniotic-fluid-derived stem cells and amniocytes have recently been determined to have wound healing effects, but their mechanism is not yet clearly understood. In this study, the effects of amniotic fluid stem cells and amniocytes on wound healing were investigated through animal experiments.

Methods On the back of Sprague-Dawley rats, four circular full-thickness skin wounds 2 cm in diameter were created. The wounds were classified into the following four types: a control group using Tegaderm disc wound dressings and experimental groups using collagen discs, amniotic fluid stem cell discs, and amniocyte discs. The wounds were assessed through macroscopic histological examination and immunohistochemistry over a period of time.

Results The amniotic fluid stem cell and amniocyte groups showed higher wound healing rates compared with the control group; histologically, the inflammatory cell invasion disappeared more quickly in these groups, and there was more significant angiogenesis. In particular, these groups had significant promotion of epithelial cell reproduction, collagen fiber formation, and angiogenesis during the initial 10 days of the wound healing process. The potency of transforming growth factor-β and fibronectin in the experimental group was much greater than that in the control group in the early stage of the wound healing process. In later stages, however, no significant difference was observed.

Conclusions The amniotic fluid stem cells and amniocytes were confirmed to have accelerated the inflammatory stage to contribute to an enhanced cure rate and shortened wound healing period. Therefore, they hold promise as wound treatment agents.

Keywords

Amniotic fluid - Stem cells - Wound healing

Publication History

Received: 22 April 2013

Accepted: 27 July 2013

Article published online:
01 May 2022

• References

• 1 Dev K, Giri SK, Kumar A. et al. Derivation, characterization and differentiation of buffalo (Bubalus bubalis) amniotic fluid derived stem cells. Reprod Domest Anim 2012; 47: 704-711
• 2 Jaramillo-Ferrada PA, Wolvetang EJ, Cooper-White JJ. Differential mesengenic potential and expression of stem cell-fate modulators in mesenchymal stromal cells from human-term placenta and bone marrow. J Cell Physiol 2012; 227: 3234-3242
• 3 Tauzin H, Humbert P, Viennet C. et al. Human amniotic membrane in the management of chronic venous leg ulcers. Ann Dermatol Venereol 2011; 138: 572-579
• 4 Uberti MG, Lufkin AE, Pierpont YN. et al. Amnion-derived cellular cytokine solution promotes macrophage activity. Ann Plast Surg 2011; 66: 575-580
• 5 Gosden CM. Amniotic fluid cell types and culture. Br Med Bull 1983; 39: 348-354
• 6 Prusa AR, Marton E, Rosner M. et al. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?. Hum Reprod 2003; 18: 1489-1493
• 7 Chung Y, Klimanskaya I, Becker S. et al. Human embryonic stem cell lines generated without embryo destruction. Cell Stem Cell 2008; 2: 113-117
• 8 Kolambkar YM, Peister A, Soker S. et al. Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol 2007; 38: 405-413
• 9 Perin L, Giuliani S, Jin D. et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif 2007; 40: 936-948
• 10 Steele MW. Letter: Chromosome analysis of human amniotic-fluid cells. Lancet 1974; 2: 1210
• 11 Rehni AK, Singh N, Jaggi AS. et al. Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice. Behav Brain Res 2007; 183: 95-100
• 12 Toda A, Okabe M, Yoshida T. et al. The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. J Pharmacol Sci 2007; 105: 215-228
• 13 Novaes Jr AB, Marchesan JT, Macedo GO. et al. Effect of in vitro gingival fibroblast seeding on the in vivo incorporation of acellular dermal matrix allografts in dogs. J Periodontol 2007; 78: 296-303